NTDUNTT DC REIT USD

🇸🇬 Singapur Borsası
0.87
SGD
Analysis Scores
Lothien Robustness Score?
39/100
Weak
Neden bu skor?
Damodaran ?
16/100
ROIC banka/finans için tanımsız — mevduat/prim fonlaması borç değil hammaddedir; değerleme öz-sermaye (P/DD) tabanlı yapılır
Dalio Risk ?
58/100
Piotroski ?
8/9
Strong
Graham ?
S$0.4
Pahalı
Active Metric?
4/4
Confidence?
67%
Lothien Robustness Summary
49/100
Lothien Sağlamlık: Orta (49/100)
Karışık sinyaller. Hem olumlu hem olumsuz göstergeler mevcut. | Kısa Vade: Nötr | Uzun Vade: Nötr | Pozitif: 4 | Negatif: 6 | Nötr: 1
Net Kâr Pozitif
Son çeyrekte S$1M net kâr açıklandı. Şirket kârlı.
Kâr Stabil
Net kâr bir önceki çeyreğe göre fazla değişmedi (%+0.0). İstikrarlı seyir.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+110.2 arttı. Büyüme trendi sağlıklı.
Çok Düşük Net Kâr Marjı
Net kâr marjı sadece %2.0. Küçük bir maliyet artışı şirketi zarara sokabilir.
Güçlü Likidite
Cari oran 2.10x — kısa vadeli borçları rahat karşılıyor.
Kârlı ama Nakit Üretemiyor
Net kâr pozitif (S$1M) ama FCF negatif (-S$381M). Yatırım harcamaları yüksek veya alacak birikimi var.
Yüksek F/K Uyarısı
Trailing F/K: 100.0. Piyasa yüksek büyüme bekliyor ya da hisse pahalı. Büyüme gerçekleşmezse düşüş riski yüksek.
Defter Değerinin Altında
PD/DD: 0.59. Hisse defter değerinin altında işlem görüyor. Değer tuzağı mı yoksa fırsat mı iyi analiz edilmeli.
Yüksek EV/EBITDA
EV/EBITDA: 17.9. Pahalı değerleme.
Düşük ROE
ROE: %0.2. Sermaye getirisi yetersiz — enflasyonun altında.
Sonraki Çeyrek: Düşüş Beklentisi
Tahminine göre kâr %-54.4 düşebilir. Sonraki bilançoya dikkat.

Data date 2026-10-23 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-23
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Düşük
252 days
Annual Volatility ?
%19.4
VaR 95% ?
%2.06
daily max loss
VaR 99% ?
%2.89
daily max loss
CVaR 95% ?
%2.69
expected loss (tail)
Max Drawdown ?
%18.1
20.01.2026 → 16.10.2026
Skewness ?
-0.07
Parametrik%2.06
Historik%2.04
Cornish-Fisher%2.06
Return Distribution
Valuation
Potential?
-24.1%
DCF Value ?
0.29
Debt Cycle?
Geç Genişleme
Balance Sheet Analysis? Q2026/6
Son 4 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-9.2 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 0.96 SGD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %2.0
Net profit margin %2.0 — positive but low. Compared to previous quarter +0.0 point increase.
ROE - Return on Equity (TTM) %0.2
ROE %0.2 — low return on equity.
EBITDA Margin %42.0
EBITDA margin %42.0 — operationally very efficient.
Gross Profit Margin %36.4
Gross profit per revenue %36.4. Evaluate relative to sector.
Free Cash Flow Margin (TTM) %-768.3
TTM Free Cash Flow is %-768.3'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio 100.0x Sector: 10.5x
F/K 100.0x — sector median's (10.5x) %852 above. Expensive zone.
P/B Ratio 0.59x Sector: 0.88x
PD/DD 0.59x — sector median's (0.88x) well below. Cheap relative to book value.
EV/EBITDA 17.9x Sector: 9.2x
EV/EBITDA 17.9x — sector median's (9.2x) %96 above. Expensive relative to EBITDA.
Indebtedness
Current Ratio 2.10x
Current ratio 2.10x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA 7.9x
Net Debt/EBITDA 7.9x — excessive leverage. Fragile debt profile.
Debt / Equity 0.43x
Low leverage — majority of assets financed by equity.
Interest Coverage 4.7x
Interest coverage 4.7x — interest obligations comfortably covered.
Growth
Revenue Growth (YoY) %+6.1
Revenue YoY %6.1 grew — positive but slow growth.
Net Profit Growth (YoY) %+110.2
Net profit turned from loss to profit (2026/3). Significant improvement.
Score Explanations
Lothien Robustness
39/100
Weak robustness (39/100). Valuation metrics and/or debt profile are unfavorable; caution is needed.
Weak
Potential
-24.1%
Minus %24.1 expected value (0.66) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %67.
Components: PE target: 0.22 | P/B target: 1.29 | EV/EBITDA target: 0.44 | DCF target: 0.29
Damodaran Valuation
16/100
Very Weak
Dalio Risk Analysis
58/100
Moderate debt risk (58/100). Interest coverage ratio 4.7x — acceptable. Debt/EBITDA 7.9x — high debt burden.
Leverage: 50/100 | Debt Service: 92/100 | Quality: 47/100
DCF Discounted Cash Flow
0.29
DCF (0.29) current price %66.3 below — cash flows do not support current price.
Current price: 0.87
Debt Cycle Phase
Geç Genişleme
Piotroski F-Score
8/9
Strong Piotroski F-Score (8/9). Profitability, leverage and operational efficiency criteria are largely met.
Strong
Graham Intrinsic Value
S$0.4
Expensive
⚖️ Sector Comparison
P/E Ratio
100.0x vs 10.5x
Sector median's %852 above — expensive
P/B Ratio
0.59x vs 0.88x
Compared to sector %33 cheaper (by book value)
EV/EBITDA
17.9x vs 9.2x
Compared to sector %96 higher EV/EBITDA
Net Profit Margin (TTM)
%2.0 vs %42.0 EBITDA margin
TTM net profit margin %2.0
TRAMA-99 Trend — Downtrend
Price (0.87), TRAMA-99 line's %9.2 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 0.87
TRAMA: 0.96
Difference: %-9.2
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
NTDU — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.